Furthermore, the serum from SSc and SLE patients cannot stimulate TLR4 expressing CHO cells to up-regulate CD25, which suggests that TLR4 could be a specific biomarker for RA [111]. The gene discussed is TLR4; the disease is systemic lupus erythematosus.